Product Details for: Immgolis
RETURN TO SEARCH RESULTS
PRODUCT LABEL
Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Subcutaneous
50MG/0.5ML (100MG/ML)
Pre-Filled Syringe
351(k) Interchangeable
Immgolis
Rx
002
Injection
Subcutaneous
100MG/ML
Pre-Filled Syringe
351(k) Interchangeable
Immgolis
Rx
003
Injection
Intravenous
50MG/4ML (12.5MG/ML)
Single-Dose Vial
351(k) Interchangeable
Immgolis Intri
Rx
Proper Name
golimumab-sldi
golimumab-sldi
Reference Product Proper Name
golimumab
golimumab
Reference Product Properietary Name
Simponi
Simponi
BLA Number
761452
761452
Applicant
Accord BioPharma Inc.
Accord BioPharma Inc.
Original Approval Date
May 15, 2026
May 15, 2026
Date of First Licensure